Campbell & Co Investment Adviser’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
VCM
VPM
Campbell & Co Investment Adviser's AMGN Position: Q1 2026 in Review
Campbell & Co Investment Adviser reduced its Amgen (AMGN) stake by 4.4% in Q1 2026, selling an estimated $230K and leaving 14,110 shares worth $4.96M. The position accounts for 0.28% of the portfolio, ranked #70.
Campbell & Co Investment Adviser first reported a position in AMGN in Q4 2014 and has held it in 14 quarters since. The position peaked at $5.38M in Q4 2024. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Campbell & Co Investment Adviser held 14,110 shares of Amgen worth $4.96M as of Q1 2026.
- Campbell & Co Investment Adviser sold 644 Amgen shares in Q1 2026, an estimated $230K.
- Amgen made up 0.28% of Campbell & Co Investment Adviser's portfolio in Q1 2026, its #70 holding.
- Campbell & Co Investment Adviser first reported a position in Amgen in Q4 2014 and has held it in 14 quarters since.
- Campbell & Co Investment Adviser's Amgen position peaked at $5.38M in Q4 2024.
- 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Campbell & Co Investment Adviser's 13F filing for Q1 2026, filed 15 May 2026.